JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

Anesth Analg 2008; 107:379-381
© 2008 International Anesthesia Research Society
doi: 10.1213/ane.0b013e318172af0f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dellaria, S. M.
Right arrow Articles by Sarode, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dellaria, S. M.
Right arrow Articles by Sarode, R.
Related Collections
Right arrow Cardiovascular
Right arrow Blood
Right arrow Preoperative Evaluation
Right arrow Coagulation

CARDIOVASCULAR ANESTHESIOLOGY

Urgent Cardiac Surgery in a Patient with a Remote History of Heparin-Induced Thrombocytopenia: Use of the Anti-PF4/Heparin ELISA Confirmatory Test

Suzanne M. Dellaria, MD*, Philip E. Greilich, MD*, and Ravindra Sarode, MD{dagger}

From the Departments of *Anesthesiology and Pain Management, {dagger}Pathology, UT Southwestern Medical Center, Dallas, Texas.

Address correspondence and reprint requests to Suzanne Dellaria, MD, 5323 Harry Hines Blvd./Dallas, TX 75390-9202. Address e-mail to suzanne.dellaria{at}utsouthwestern.edu.

Abstract

The use of established heparin protocols when heparin-induced thrombocytopenia (HIT) antibodies are negative is currently recommended for the management of patients with previous HIT who require cardiac surgery. Routine preoperative testing for HIT antibodies using an anti-PF4/heparin enzyme-linked immunosorbent assay (ELISA) introduces the problem of detecting nonpathogenic HIT antibodies, which can lead to a false diagnosis of the presence of platelet-activating antibodies. Our case report demonstrates the clinical utility of a newer confirmatory procedure performed using high dose heparin. We use this procedure in situations in which pretest probability is low (remote HIT) and the anti-PF4/heparin ELISA test results are weak to moderately positive (absorbance 0.4-1.0).




This article has been cited by other articles:


Home page
 BloodHome page
S. Selleng, A. Haneya, S. Hirt, K. Selleng, C. Schmid, and A. Greinacher
Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation
Blood, November 15, 2008; 112(10): 4024 - 4027.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. Greinacher and J. H. Levy
HIT Happens: Diagnosing and Evaluating the Patient with Heparin-Induced Thrombocytopenia
Anesth. Analg., August 1, 2008; 107(2): 356 - 358.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2008 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2008 by the International Anesthesia Research Society.